Myeloperoxidase release after allergen-specific conjunctival challenge

Journal of Asthma

Volumn 41, Issue 6, 2004, Pages 639-643

  Monteseirin J ^a,b,d   Fernandez Pineda I ^b   Chacon P ^a   Vega, A ^a   Bonilla, I ^a   Camacho, M J ^a   Fernandez Delgado L ^a   Conde, J ^a   Sobrino, F ^a,c  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b Sacred Heart Clinic   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

^d NONE   (Spain)

Author keywords

Allergen; Allergen challenge; Allergy; Conjunctiva; IgE dependent; Mechanism; Myeloperoxidase; Neutrophils; Ocular; Release; Rhinoconjunctivitis

Indexed keywords

ALLERGEN; DACTYLIS GLOMERATA EXTRACT; MYELOPEROXIDASE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALLERGEN SPECIFIC CONJUNCTIVAL CHALLENGE; ALLERGIC CONJUNCTIVITIS; ALLERGIC INFLAMMATION; ALLERGIC RHINITIS; ALLERGY; ARTICLE; ATOPY; AZUROPHIL GRANULE; CELL GRANULE; CELL INFILTRATION; CLINICAL ARTICLE; CONJUNCTIVA; CONJUNCTIVA SAC; CONTROLLED STUDY; DACTYLIS; DACTYLIS GLOMERATA; DRUG ADMINISTRATION; ENZYME IMMUNOASSAY; ENZYME RELEASE; HAY FEVER; HUMAN; IMMUNOTHERAPY; INFLAMMATION; NEUTROPHIL; PROVOCATION TEST;

ALLERGENS; CASE-CONTROL STUDIES; CONJUNCTIVA; CONJUNCTIVITIS, ALLERGIC; DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; PATCH TESTS; PEROXIDASE; PROBABILITY; REFERENCE VALUES; RHINITIS, ALLERGIC, PERENNIAL; SENSITIVITY AND SPECIFICITY;

EID: 9244263577     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.1081/JAS-200026407     Document Type: Article

References (17)

1. Sub-committee on skin tests of the EAACI: skin tests used in type I allergy testing. Position paper. Allergy 1989; 44(suppl 10):1-59.
2. Ciprandi G, Buscaglia S, Pesce GP, Passalacqua G, Rihoux JP, Bagnasco M, Canonica GW. Cetirizine reduces inflammatory cell recruitment and ICAM-1/CD54 expression on conjunctival epithelium both in early and late phase events following allergen specific challenge. J Allergy Clin Immunol 1995; 95:612-621.
3. Friedlander MH. Ocular allergy. In: Middleton E, Reed CE, Ellis EF, Adkinson NF, Younginger JW, Busse WW, eds. Allergy: Principles and Practice. St. Louis: Mosby, 1993:1649-1660.
4. Ciprandi G, Buscaglia S, Pronzato C, Benvenuti C, Cavalli E, Bruzzone F, Canonica W. Oxotamide reduces inflammatory events induced by allergen-specific conjunctival challenge. Ann Allergy Asthma & Immun 1995; 75:446-452.
5. Ciprandi G, Buscaglia S, Catrullo A, Paolieri F, Riccio AM, Fiorino N, Canonica GW. Antiallergic activity of topical lodoxamide on in vivo and in vitro models. Allergy 1996; 51:946-951.
6. Nordic Council of Medicines. Guidelines for the Registration of Allergen Preparations. Uppsala, Sweden: Nordic Council of Medicines, 1980.
7. Abelson MD, Chambers WA, Smith LM. Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol 1990; 108:84-88.
8. Leonardo A, Borghesan F, Avarello A, Plebani M, Secchi AG. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis. Br J Ophthalmol 1997; 81:23-26.
9. Truong MJ, Gruart V, Kusnierz JP, Papin JP, Loiseau S, Capron A, Capron M. Human neutrophils express immunoglobulin E (IgE)-binding proteins (Mac2/εBP) of the S-type lectin family: role in IgE-dependent activation. J Exp Med 1993; 117:243-248.
10. Monteseirín J, Camacho MJ, Montaño R, Llamas E, Conde M, Carballo M, Guardia P, Conde J, Sobrino F. Enhancement of antigen-specific functional responses by neutrophils from allergic patients. J Exp Med 1996; 183:2571-2579.
11. Collison KS, Kwaasi AA, Parhar RS, al-Sedairy ST, al-Mohanna FA. Monomeric human IgE evokes a transient calcium rise in individual human neutrophils. J Leukoc Biol 1995; 58:459-467.
12. Carlson M, Håkansson L, Peterson Ch, Stålenheim G, Venge P. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991; 87:27-33.
13. Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med 1997; 155:449-453.
14. Jacobi HH, Poulsen LK, Reimert CM, Skov PS, Ulfgren AK, Jones I, Elfman LB, Malling HJ, Mygind N. IL-8 and the activation of eosinophils and neutrophils following nasal allergen challenge. Int Arch Allergy Immunol 1998; 116:53-59.
15. Palczynski C, Krakowiak A, Ruta U, Krajewska B, Rudzinski J, Gielec L, Górski P. Nasal response to allergen challenge in patients with immediate asthmatic reaction. Allergol Immunopathol 1996; 24:163-168.
16. Leonardi A, Borghesan F, Faggian D, Depaoli M, Secchi AG, Plebani M. Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases. Am J Ophthalmol 2000; 129:151-158.
17. Rak S, Bjömson A, Håkanson L, Sörenson S, Venge P. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. J Allergy Clin Immunol 1991; 88:878-888.